Synjardy Uses
Table of Contents
- What is Synjardy?
- How Does Synjardy Work?
- Primary Uses of Synjardy
- Potential Side Effects
- Conclusion
What is Synjardy?
Synjardy is an oral medication aimed at improving blood sugar control in adults with type 2 diabetes. Manufactured by Boehringer Ingelheim Pharmaceuticals, Inc., it combines two active ingredients: empagliflozin and metformin hydrochloride. Empagliflozin helps the kidneys remove glucose from the blood, while metformin decreases glucose production in the liver and improves your body’s response to insulin.
How Does Synjardy Work?
The dual mechanism of Synjardy targets high blood sugar through complementary pathways.
1. Empagliflozin
- SGLT2 Inhibitor: Empagliflozin works by blocking the sodium-glucose co-transporter 2 (SGLT2) protein in the kidneys, reducing glucose reabsorption and increasing glucose excretion in the urine.
2. Metformin
- Biguanide: Metformin lowers blood glucose by decreasing the amount of sugar your liver releases into the blood and improving your muscles’ ability to absorb and use sugar.
By leveraging these two pathways, Synjardy offers multifaceted support in managing type 2 diabetes.
Primary Uses of Synjardy
Synjardy is primarily prescribed for managing blood sugar levels in adults with type 2 diabetes. Below are some specific applications and benefits of using Synjardy:
Blood Sugar Control
- Enhanced Glucose Management: The combination therapy provides comprehensive blood sugar control, making it easier to keep glucose levels stable.
Cardiovascular Benefits
- Heart Health: Empagliflozin has been shown to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.
Weight Loss
- Weight Management: Some individuals may experience weight loss as an additional benefit, helping to improve overall health.
For a more detailed explanation, check the Synjardy uses page.
Potential Side Effects
While effective in managing blood sugar levels, Synjardy may cause side effects in some individuals.
Common Side Effects
- Gastrointestinal Issues: Nausea, vomiting, and diarrhea are common, particularly with metformin.
- Urinary Tract Infections: Due to empagliflozin’s action on the kidneys, some patients may experience urinary tract infections.
Serious Side Effects
- Lactic Acidosis: A rare but severe condition associated with metformin, characterized by high levels of lactic acid in the blood.
- Ketoacidosis: Although rare, empagliflozin can rarely lead to ketoacidosis, a potentially life-threatening condition.
Consult your healthcare provider and read more about potential side effects from credible sources like the American Diabetes Association.
Conclusion
Synjardy offers a powerful combination therapy for managing type 2 diabetes by leveraging the benefits of empagliflozin and metformin. With benefits extending from blood sugar control to cardiovascular health and potential weight loss, Synjardy constitutes an important option in diabetes management. However, like all medications, it comes with potential side effects that should be carefully monitored. Always consult your healthcare provider for personalized advice.
For more information, don’t forget to visit our Synjardy uses page.
Leave a Reply